The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
Designed for intense clinical environments, Rembra can handle up to 270 exams per day
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research
The facility is dedicated to breakthrough innovations in laboratory instruments that detect infectious diseases, cancer, and blood disorders
The deal brings three high-quality small-molecule drug substance sites into Siegfried’s portfolio
Siegfried plans to grow its exclusive synthesis business in the US by optimizing controlled substance capacity at the Wilmington and nearby Pennsville sites
TruVerus is the only FDA cleared, multi-modal platform capable of delivering comprehensive routine testing from a single lithium heparin sample
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
